1
Oct 2026
Cognitive tests may not tell the whole story about memory concerns
This study highlights the link between blood biomarkers and dementia risk in subjective cognitive decline, emphasizing prevention and lifestyle changes.
Stay Informed!
1
Oct 2026
Cognitive tests may not tell the whole story about memory concerns
This study highlights the link between blood biomarkers and dementia risk in subjective cognitive decline, emphasizing prevention and lifestyle changes.
1
Oct 2026
Esophageal cancer leaves a distinct metabolic signature in the gut
The study uncovers gut microbial and metabolic signatures in esophageal cancer, emphasizing lipid dysregulation and its potential role in disease progression.
1
Oct 2026
Novel surgical technique restores clitoral sensation using buccal mucosa graft
For women who lose part of their clitoris because of vulvar cancer, a clitoral reconstruction procedure has now been developed for the first time. This comes forty years after the first penile reconstruction surgery. Results in the initial group of patients are encouraging.
1
Oct 2026
Real-world data reveals higher reported GLP-1 side effects in female patients
The second of a Series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health discusses the wide-ranging issues relating to use of GLP-1 RA drug use in women.
1
Oct 2026
GLP-1 receptor agonist exposure shows no link to major adverse pregnancy outcomes
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health shows that, following a review and meta-analysis of available studies, use of glucagon-like peptide-1 receptor agonists (GLP-1 RA) drugs for diabetes and weight management in women living with diabetes is not associated with adverse pregnancy outcomes in most cases.
1
Oct 2026
Study examines driving cessation in dementia and MCI
Flinders University researchers have investigated the reactions of people with dementia and mild cognitive impairment (MCI), in the hope of finding a process that best supports the person with dementia.
1
Oct 2026
Early-onset type 2 diabetes trial demonstrates significant 24-week fat loss
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Regional Health Americas journal shows that in people who have developed early onset type 2 diabetes (EOT2D) (aged under 45 years), around half these T2D cases can be reversed with a low-energy diet combined with a structured exercise program.
1
Oct 2026
Fluorescent sensors could help researchers see diabetes in action
Researchers from the University of Bath have developed fluorescent molecular probes that can detect changes in glucose levels inside living animals, giving scientists new ways of visualizing sugar uptake, studying diabetes, cancer and other metabolic diseases in whole organisms in real time.
1
Oct 2026
Honeybee silk could power smarter wound dressings
Biodegradable films made from engineered honeybee silk could form the basis of a new generation of ‘smart’ wound dressings, according to CSIRO and Adelaide University researchers.
